Biomerica CFO reports multiple stock option grants
Newly reported finance executive at BIOMERICA INC discloses several existing multi-year stock option awards in a Form 3 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BIOMERICA INC (BMRA) filed an initial insider ownership report for Qu Xiaoxuan, who serves as Principal Financial Officer and Principal Accounting Officer. The filing lists existing stock option awards covering 4,300 shares at $2.13, 4,188 shares at $2.64, 1,875 shares at $7.28, and 1,000 shares at $9.44, all for common stock. These options vest in four equal annual installments beginning on dates from August 21, 2024 through April 10, 2027, subject to continued service, and any vested options expire 90 days after the officer’s termination, with final expiration dates between August 21, 2033 and April 10, 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
Footnotes (4)
- F1. The option vests in four equal annual installments beginning on April 10, 2027, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
- F2. The option vests in four equal annual installments beginning on January 9, 2026, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
- F3. The option vests in four equal annual installments beginning on January 18, 2025, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
- F4. The option vests in four equal annual installments beginning on August 21, 2024, subject to the reporting person's continued service through each applicable vesting date. Additionally, all vested options shall expire 90 days following the reporting person's termination.
Key Figures
Key Terms
stock option financial
vesting financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing for BMRA disclose about Qu Xiaoxuan?
What are the main terms of the $2.64 stock option reported for BMRA?
What higher-price stock options does the BMRA officer hold?
AI-generated analysis. How Rhea-AI works. Not financial advice.